|

Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study

RECRUITINGSponsored by Candiolo Cancer Institute - IRCCS
Actively Recruiting
SponsorCandiolo Cancer Institute - IRCCS
Started2023-05-01
Est. completion2025-12-01
Eligibility
Age18 Years – 55 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06458764

Summary

Primary objectives: * To estimate Sexual Dysfunction (SD) incidence in premenopausal breast cancer patients treated by surgery and taking endocrine therapy. * To detect the presence of SD-related distress in the population, as a determining factor in the maintenance of a good quality of life. Secondary objectives: * To describe SD characteristics determining the most frequently reported symptoms and correlations with type of surgery or therapeutic regimens. * Collect baseline data for subsequent randomized trials involving practical interventions with the aim to reduce SD prevalence in this population.

Eligibility

Age: 18 Years – 55 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* women aged ≥18 and ≤ 55
* who underwent surgery for early stage breast cancer
* taking endocrine therapy for at least 3 months
* providing an informed consent and completing the study questionnaires.

Exclusion Criteria:

* withdrawal of the informed consent, at any time

Conditions5

Breast CancerBreast Cancer FemaleCancerPremenopausal Breast CancerSexual Dysfunction

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.